News Releases

Date Title and Summary Additional Formats
Toggle Summary HTG and Icahn School of Medicine at Mount Sinai Announce Bladder Cancer Research Collaboration
HTG’s Innovative Transcriptome Panel Technology to be Leveraged in Retrospective Studies TUCSON, Ariz. , Nov. 17, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling
View HTML
Toggle Summary HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TUCSON, Ariz. , Nov. 15, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that, on November 9, 2021 the Compensation Committee of the
View HTML
Toggle Summary HTG Molecular Diagnostics Reports Third Quarter 2021 Results
Call scheduled for today, November 10, at 4:30 pm ET TUCSON, Ariz. , Nov. 10, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported its
View HTML
Toggle Summary HTG Molecular Diagnostics to Announce Third Quarter 2021 Financial Results and Host Conference Call on Wednesday, November 10
TUCSON, Ariz. , Nov. 02, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a life science company advancing precision medicine through its transcriptome-wide technology, today announced that it will report its financial results for the third quarter ended September 30, 2021
View HTML
Toggle Summary HTG Expands Therapeutics Team
Veteran Drug Developer Stephen Barat, Ph.D. Joins to Head Company’s Therapeutics Division TUCSON, Ariz. , Oct. 05, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling
View HTML
Toggle Summary HTG Molecular Diagnostics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
TUCSON, Ariz. , Sept. 21, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that company management will present in a fireside chat in Cantor Fitzgerald’s Virtual Global Healthcare
View HTML
Toggle Summary HTG Molecular Diagnostics to Present at H.C. Wainwright’s 23rd Annual Global Investment Conference
TUCSON, Ariz. , Sept. 08, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that company management will participate in H.C. Wainwright’s 23rd Annual Global Investment Conference ,
View HTML
Toggle Summary HTG Molecular Diagnostics Reports Second Quarter 2021 Results
Call scheduled for today, August 12, at 4:30pm ET TUCSON, Ariz. , Aug. 12, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the quarter ended June 30, 2021
View HTML
Toggle Summary HTG’s New HTG Transcriptome Panel Launched with Commercial Availability in the U.S. and Europe
HTG Transcriptome Panel designed to measure approximately 20,000 mRNA targets using the  HTG EdgeSeq technology Intended to serve as one of the technological cornerstones for the  recently announced HTG Therapeutics Business Unit A third white paper highlighting the HTG Transcriptome Panel’s
View HTML
Toggle Summary HTG Molecular Diagnostics to Announce Second Quarter 2021 Financial Results and Host Conference Call on Thursday, August 12
TUCSON, Ariz. , Aug. 03, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report its financial results for the second quarter ended June 30, 2021 after the market close on
View HTML